BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Ovarian cancer AND FLT3, STK1, 2322, ENSG00000122025, P36888, FLK2, CD135, RP11-153M24_3
32987 results:

  • 1. Oocyte collection and outcome following oncologic treatment: a retrospective multicentre study.
    Fernández-González MJ; Borgmann-Staudt A; Llagostera CG; Ceballos-Garcia E; Gebauer J; Jantke A; Barnbrock A; Kentenich H; Klco-Brosius S; Lotz L; Balcerek M
    Support Care Cancer; 2024 May; 32(6):390. PubMed ID: 38806697
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic impact of suspicious extraabdominal lymph nodes on patient survival in advanced ovarian cancer.
    Park K; Kwon JY; Song JM; Pyeon SY; Lee SH; Chung YS; Lee JM
    PLoS One; 2024; 19(5):e0299205. PubMed ID: 38805507
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epithelial ovarian cancer and brain metastases: might the
    Sassu CM; Marchetti C; Russo G; Minucci A; Boccia SM; Benato A; Nero C; Piermattei A; Mattogno PP; Giannarelli D; Ferrandina G; Olivi A; Fagotti A; Scambia G
    Int J Gynecol Cancer; 2024 Jan; 34(1):88-98. PubMed ID: 38805344
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The Impact of Mitochondria in ovarian cancer Cell Metabolism, Proliferation, and Metastasis.
    Schatten H
    Adv Exp Med Biol; 2024; 1452():119-125. PubMed ID: 38805128
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. [Analysis of sequential chemotherapy efficacy in ovarian epithelial carcinoma, fallopian tube carcinoma and primary peritoneal carcinoma].
    Shen XY; Li XP; Wang Y; Wu Y; Li Y; Yang YC; Wei LH; Fan Y; Tang ZQ
    Zhonghua Fu Chan Ke Za Zhi; 2024 May; 59(5):383-390. PubMed ID: 38797568
    [No Abstract]    [Full Text] [Related]  

  • 6. Anticancer Effects of the Novel Pyrazolyl-Urea GeGe-3.
    Williams A; Cooper E; Clark B; Perry L; Ponassi M; Iervasi E; Brullo C; Greenhough A; Ladomery M
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791418
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. CA-125 KELIM as an Alternative Predictive Tool to Identify Which Patients Can Benefit from PARPi in High-Grade Serous Advanced ovarian cancer: A Retrospective Pilot Diagnostic Accuracy Study.
    Zouzoulas D; Tsolakidis D; Tzitzis P; Chatzistamatiou K; Theodoulidis V; Sofianou I; Grimbizis G; Timotheadou E
    Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791269
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comprehensive Bioinformatic Investigation of TP53 Dysregulation in Diverse cancer Landscapes.
    Khan R; Pari B; Puszynski K
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790205
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Transcriptome profiling and characterization of peritoneal metastasis ovarian cancer xenografts in humanized mice.
    Kang SW; Lee JY; Kang OJ; Kim YM; Choi EK; Lee SW
    Sci Rep; 2024 May; 14(1):11894. PubMed ID: 38789484
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Preoperative cancer antigen-125 levels as a predictor of recurrence in early-stage endometrial cancer.
    Erturk A; Korkmaz E; Arslantas Z; Bekdemir S; Erturk NK
    Rev Assoc Med Bras (1992); 2024; 70(5):e20231115. PubMed ID: 38775501
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Racial and Ethnic Inequities in cancer Care Continuity During the COVID-19 Pandemic Among Those With SARS-CoV-2.
    Islam JY; Hathaway CA; Hume E; Turner K; Hallanger-Johnson J; Tworoger SS; Camacho-Rivera M
    JAMA Netw Open; 2024 May; 7(5):e2412050. PubMed ID: 38767916
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Construction and Validation of a Nomogram to Predict the Postoperative Venous Thromboembolism Risk in Patients with HGSOC.
    Huang Z; Li L; Gong Z; Tang L
    Clin Appl Thromb Hemost; 2024; 30():10760296241255958. PubMed ID: 38767088
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Fertility preservation in female cancer patients in Brazil: perceptions and attitudes of infertility specialists.
    Ranniger RL; Lamaita RM; D'Abreu BF; Tolentino MR; Cândido EB; Andrade WP; Nogueira-Rodrigues A; Silva-Filho AL
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765513
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Dual‑regulated oncolytic adenovirus carrying
    Zhao T; Ye W; Zhang R; Zhu X; Shi Q; Xu X; Chen W; Xu L; Meng Y
    Mol Med Rep; 2024 Jul; 30(1):. PubMed ID: 38757346
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Exploratory biomarker analysis in the phase III L-MOCA study of olaparib maintenance therapy in patients with platinum-sensitive relapsed ovarian cancer.
    Li H; Peng Z; Zhu J; Zhao W; Huang Y; An R; Zheng H; Qu P; Wang L; Zhou Q; Wang D; Lou G; Wang J; Wang K; Kong B; Xie X; Yin R; Low J; Rozita AM; Sen LC; Meng YC; Kiong KS; Liu J; Liang Z; Lv W; Zhu Y; Hu W; Sun W; Su J; Wang Q; Zang R; Ma D; Gao Q
    BMC Med; 2024 May; 22(1):199. PubMed ID: 38755585
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Niraparib, Dostarlimab, and Bevacizumab as Combination Therapy in Pretreated, Advanced Platinum-Resistant ovarian cancer: Findings From Cohort A of the OPAL Phase II Trial.
    Liu JF; Gaillard S; Wahner Hendrickson AE; Yeku O; Diver E; Gunderson Jackson C; Arend R; Ratner E; Samnotra V; Gupta D; Chung J; Zhang H; Compton N; Baines A; Bacqué E; Liu X; Felicetti B; Konecny GE
    JCO Precis Oncol; 2024 May; 8():e2300693. PubMed ID: 38754056
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in cancer: A Systematic Review and Meta-Analysis.
    Gao L; Fan J; He J; Che X; Wang X; Han C
    Technol Cancer Res Treat; 2024; 23():15330338241245939. PubMed ID: 38752263
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. CircAGFG1 Promotes ovarian cancer Progression Through the miR-409-3 p/ZEB1 Axis.
    Luo J; Zhong H; Guo M; Xiao P; Cao R; Zhao M; Jing Y
    Technol Cancer Res Treat; 2024; 23():15330338241252423. PubMed ID: 38752261
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification of necroptosis-related gene signatures for predicting the prognosis of ovarian cancer.
    Qin Y; Sheng Y; Ren M; Hou Z; Xiao L; Chen R
    Sci Rep; 2024 May; 14(1):11133. PubMed ID: 38750159
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Characterization of innate lymphoid cell subsets infiltrating melanoma and epithelial ovarian tumors.
    Chung DC; Ghaedi M; Warner K; Sayad A; Saibil SD; Bernardini MQ; Clarke BA; Shaw PA; Butler MO; Easson A; Morrissy S; Wang BX; Nguyen L; Ohashi PS; Jacquelot N
    Oncoimmunology; 2024; 13(1):2349347. PubMed ID: 38746870
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1650.